Analyst Ratings For NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
Today, Canaccord Genuity reiterated its Buy ➝ Positive rating on NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX) with a price target of $215.00 ➝ $225.00.
Some recent analyst ratings include
- 5/7/2018-Canaccord Genuity Reiterated Rating of Buy ➝ Positive.
- 12/8/2017-Aegis Reiterated Rating of Sell.
- 7/28/2017-CL King Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
- 2/3/2017-Feltl & Co. was Downgraded by analysts at Feltl & Co. from a “Hold ➝ Sell” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX) has insider ownership of 2.56% and institutional ownership of 86.97%.
- On 2/28/2018 Daniel M Junius, Director, sold 2,974 with an average share price of $190.06 per share and the total transaction amounting to $565,238.44.
- On 2/22/2018 William T End, Director, sold 4,000 with an average share price of $184.48 per share and the total transaction amounting to $737,920.00.
- On 2/14/2018 Lawrence D Kingsley, Director, bought 1,000 with an average share price of $178.05 per share and the total transaction amounting to $178,050.00.
- On 2/8/2018 Jonathan W Ayers, Chairman, sold 22,000 with an average share price of $177.52 per share and the total transaction amounting to $3,905,440.00.
- On 2/7/2018 Bruce L Claflin, Director, bought 1,000 with an average share price of $179.58 per share and the total transaction amounting to $179,580.00.
- On 2/6/2018 Jonathan W Ayers, Chairman, sold 36,000 with an average share price of $179.28 per share and the total transaction amounting to $6,454,080.00.
- On 2/5/2018 Brian P Mckeon, VP, sold 6,602 with an average share price of $181.36 per share and the total transaction amounting to $1,197,338.72.
Recent Trading Activity for NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
Shares of NASDAQ:IDXX – Idexx Laboratories closed the previous trading session at 207.52 down -4.68 2.20% with 215.75 shares trading hands.